Us2.ai

Us2.ai is a medtech startup based in Singapore that specializes in AI-powered software for automated echocardiography analysis. Founded in 2017, the company aims to enhance patient outcomes and broaden healthcare access by democratizing echocardiograms through advanced technology. Us2.ai's flagship product, Echo Copilot™, is an FDA-cleared and CE-marked solution that automates the analysis of all heart chambers, generating comprehensive reports in under two minutes.

The company utilizes machine learning to detect and analyze cardiovascular diseases through ultrasound imaging. Echo Copilot™ offers over 45 automated echo parameters and real-time interpretation compatible with various ultrasound devices. Us2.ai has established partnerships with hardware vendors, pharmaceutical companies, and healthcare providers worldwide, and has received significant funding to support its growth and innovation in the echocardiography AI market.